BSX Q1 2020 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q1 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.5B+2.0% YoY

Gross Profit

$1.5B59.5% margin

Operating Income

$223M8.8% margin

Net Income

$11M0.4% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

-12.5%

Cash Flow

Operating Cash Flow

-$77M

Free Cash Flow

-$179M

Stock-Based Comp.

$42M

Balance Sheet

Total Assets

$30.1B

Total Liabilities

$16.3B

Stockholders' Equity

$13.8B

Cash & Equivalents

$370M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.5B	$2.5B	+2.0%
Gross Profit	$1.5B	$1.6B	-5.1%
Operating Income	$223M	$429M	-48.0%
Net Income	$11M	$424M	-97.4%

Revenue Segments

Cardiovascular

$1.0B57%

MedSurg

$774M43%

Geographic Segments

UNITED STATES

$1.5B59%

Non-US

$1.1B41%